| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b92820152dd3139e16dc01e7e4bec9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_409840e9594b3c11cd4b347294fe405b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58833d6c0dc5cfab5bbd7e8354619752
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02471b6e80ca776c83c704c0e9a19c8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97b41b75ce53c2798b5c9965517b2313 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-22 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-75 |
| filingDate |
1994-05-11^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf7ca961d5607897e28d487d7ba66955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f9cbdfef7d6345d0c3a76652e8abcb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dc9708bfdf6c2d331a1ec23b9234c21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29b37f82319242f31d726b99d766e039 |
| publicationDate |
1994-12-08^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9427601-A1 |
| titleOfInvention |
Aliphatic amino bis-aryl squalene synthase inhibitors |
| abstract |
This invention relates to a class of novel aliphatic amino bis-aryl compounds containing at least four carbon atoms and an amino group either substituted thereon or incorporated therein and is furhter linked or bridged to two mono- and/or bicyclic rings. Compounds of this invention reduce levels of serum cholesterol in the body without significantly reducing mevalonic metabolite synthesis. This invention relates also to pharmacological compositions and method of treatment for lowering serum cholesterol levels using the compounds of this invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0801644-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015523402-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6855843-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0801644-A4 |
| priorityDate |
1993-05-21^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |